Enoxaparin Sodium Injection
Product Images NDC 71288-426

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 71288-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Eno0g 0000 01)

Chemical structure diagram illustrating the repeating disaccharide units of Enoxaparin Sodium, showing sugar rings with substituent groups including sodium carboxylates and sulfate groups, consistent with its characterization as a low molecular weight heparin derivative.*

FDA Label Image

Structural Formula (Eno0g 0000 02)

Chemical structure diagram of Enoxaparin Sodium, depicting molecular bonds and functional groups characteristic of this anticoagulant agent.*

FDA Label Image

Figure 1 (Eno0g 0000 03)

A forest plot showing relative risk comparisons between UFH and Enoxaparin (Enox) across various patient subgroups. The chart lists subgroups with patient counts and displays relative risk with confidence intervals. The horizontal axis indicates whether Enoxaparin or UFH is favored. Percentages of risk for UFH and Enox, along with reduction in risk percentages, are shown for each subgroup and overall.*

FDA Label Image

Figure 2 (Eno0g 0000 04)

A survival curve chart comparing the hazard distribution function for Enoxaparin Sodium injection versus UFH (unfractionated heparin) over time to death or myocardial re-infarction in days. The main figure covers up to 30 days, with an inset graph displaying data up to 1 year. Both charts include log-rank test p-values indicating statistical comparison. The chart also provides the number of patients at risk during the study timeline.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 3 mL Carton (Enox Carton Dl)

Packaging label for Enoxaparin Sodium Injection, USP 300 mg per 3 mL (100 mg per mL) multi-dose vial by Meitheal Pharmaceuticals Inc. The label states it is for subcutaneous or intravenous injection and contains one 3 mL vial. Storage instructions, warnings, and manufacturer information are also included on the label.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 3 mL Container Label (Enox Vial Dl)

Label for Enoxaparin Sodium Injection, USP 300 mg per 3 mL (100 mg per mL) by Meitheal Pharmaceuticals Inc. The label states it is for subcutaneous or intravenous injection and includes storage instructions and a barcode. Manufacturer information and trademark details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.